Vaccine Adjuvants Market Players:
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- GSK plc
- SK Bioscience
- Sanofi
- Abbott
- Phibro Animal Health Corporation
- Astrazeneca
- Novavax, Inc.
- Agenus Inc.
- Astellas Pharma Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of the vaccine adjuvants was over USD 1.31 billion.
The market size for the vaccine adjuvants is projected to reach USD 2.3 billion by the end of 2036 expanding at a CAGR of 5.8% during the forecast period i.e., between 2027-2036.
North America vaccine adjuvants market will dominate more than 35% share by 2036, driven by a large elderly population and increasing prevalence of chronic diseases.
Key players in the market include Pfizer Inc., GSK plc, SK Bioscience, Sanofi, Abbott, Phibro Animal Health Corporation, Astrazeneca, Novavax, Inc., Agenus Inc., Astellas Pharma Inc.
